Robert W Selander sold $685k of HQY
director at HEALTHEQUITY, INC.. 8,250 shares at an average of $82.98, traded Oct 9, 2024, filed Oct 11, 2024.
Score components
- +15RoleDirector
- +21Trade size$685k at market
- +5Share of holdings soldSold 14% of holdings
- +8Cluster2 insiders selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m +15.7%, 3m +17.4%, 6m -3.8%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001415889-24-025043, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Oct 9, 2024 | MOption exercise Common Stock10b5-1 | +12,500 | $28.68 | $359k | 60,469 | Oct 11, 2024 |
| Oct 9, 2024 | SOpen-market sale Common Stock10b5-1 | -1,504 | $82.07 | $123k | 58,965 | Oct 11, 2024 |
| Oct 9, 2024 | SOpen-market sale Common Stock10b5-1 | -4,171 | $83.27 | $347k | 54,794 | Oct 11, 2024 |
| Oct 9, 2024 | SOpen-market sale Common Stock10b5-1 | -75 | $83.77 | $6,283 | 54,719 | Oct 11, 2024 |
| Oct 9, 2024 | MOption exercise Common Stock10b5-1 | +7,500 | $21.27 | $160k | 62,219 | Oct 11, 2024 |
| Oct 9, 2024 | SOpen-market sale Common Stock10b5-1 | -752 | $82.27 | $62k | 61,467 | Oct 11, 2024 |
| Oct 9, 2024 | SOpen-market sale Common Stock10b5-1 | -1,748 | $83.34 | $146k | 59,719 | Oct 11, 2024 |
| Oct 9, 2024 | MOption exercise Stock Option (right to buy)derivative10b5-1 | -12,500 | $0.00 | $0 | 37,500 | Oct 11, 2024 |
| Oct 9, 2024 | MOption exercise Stock Option (right to buy)derivative10b5-1 | -7,500 | $0.00 | $0 | 7,500 | Oct 11, 2024 |
Related signals
Other insiders at HEALTHEQUITY, INC. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 7Weak | HEALTHEQUITY, INC. | Adrian T Dillon director | $798k 7,632 shares | -11% | |
| 7Weak | HEALTHEQUITY, INC. | Michael Henry Fiore EVP, CHIEF COMMERCIAL OFFICER | $224k 2,354 shares | -4% | |
| 8Weak | HEALTHEQUITY, INC. | Michael Henry Fiore EVP, CHIEF COMMERCIAL OFFICER | $235k 2,470 shares | -4% | |
| 24Weak | HEALTHEQUITY, INC. | Michael Henry Fiore EVP, CHIEF COMMERCIAL OFFICER | $298k 3,142 shares | -5% | |
| 30Weak | HEALTHEQUITY, INC. | Delano Ladd EVP, General Counsel | $675k 7,500 shares | -8% | |
| 12Weak | HEALTHEQUITY, INC. | Gayle Furgurson Wellborn director | $220k 2,439 shares | -11% | |
| 21Weak | HEALTHEQUITY, INC. | Delano Ladd EVP, General Counsel | $142k 1,500 shares | -2% | |
| 60Notable | HEALTHEQUITY, INC. | Elimelech Rosner EVP, CHIEF TECHNOLOGY OFFICER | $1.0M 10,959 shares | -19% | |
| 37Weak | HEALTHEQUITY, INC. | Gayle Furgurson Wellborn director | $425k 4,339 shares | -18% | |
| 6Weak | HEALTHEQUITY, INC. | Delano Ladd EVP, General Counsel | $157k 1,500 shares | -2% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.